In summary, in this pilot study, a LCKD led to significant reductions in weight, percent free testosterone, LH/FSH ratio, and fasting serum insulin in women with obesity and PCOS over a six-month period. Here, PLOD1 is linked to obesity due to melanocortin 4 receptor deficiency.